Pharmacokinetics of intravenous pentosan polysulphate (HOE/BAY 946) in HIV-positive patients

Malte Peters; Myriam Witvrouw; De Clercq Erik; B. Ruf

doi:10.1097/00002030-199112000-00021

Abstract

1 min read

Department of Internal Medicine, Division of Infectious Diseases, Rudolf Virchow University Hospital, Free University of Berlin, D-100 Berlin 65, Germany * Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1992

TIBO derivatives: a new class of highly potent and specific inhibitors of HIV-1 replication

Rudi Pauwels, Koen Andries, Zeger Debyser, Michael J. Kukla, Dominique Schols, Jan Desmyter, De Clercq Erik, Paul A. J. Janssen

Article1982

Differential Effects of E-5-(2-Bromovinyl)-2'-Deoxyuridine on Infections with Herpes Simplex Virus Type 1 and Type 2 in Hairless Mice

De Clercq Erik, Z.-X. Zhang

Article2005

New Approaches toward Anti-HIV Chemotherapy

De Clercq Erik

Article1997

A Methylated Derivative of 5‘-Noraristeromycin

Katherine L. Seley‐Radtke, Stewart W. Schneller, De Clercq Erik

Article1994

Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance

Sanjeev Krishna, Deborah Waller, Feiko O. ter Kuile, Dominic Kwiatkowski, Jane Crawley, Charles Craddock, François Nosten, D. Chapman, David Brewster, PAH Holloway, Sir Nicholas White

Transactions of the Royal Society of Tropical Medicine and Hygiene